These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7613235)

  • 1. Cerebral arteritis associated with oral use of phenylpropanolamine: report of a case.
    Ryu SJ; Lin SK
    J Formos Med Assoc; 1995; 94(1-2):53-5. PubMed ID: 7613235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Benign cerebral angiopathies and phenylpropanolamine].
    Le Coz P; Woimant F; Rougemont D; Sanson M; Laplane D; Haguenau M; Pépin B
    Rev Neurol (Paris); 1988; 144(4):295-300. PubMed ID: 3047837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral vasculitis and hemorrhage in an adolescent taking diet pills containing phenylpropanolamine: case report and review of literature.
    Forman HP; Levin S; Stewart B; Patel M; Feinstein S
    Pediatrics; 1989 May; 83(5):737-41. PubMed ID: 2654866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylpropanolamine: an over-the-counter drug causing central nervous system vasculitis and intracerebral hemorrhage. Case report and review.
    Glick R; Hoying J; Cerullo L; Perlman S
    Neurosurgery; 1987 Jun; 20(6):969-74. PubMed ID: 2956531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case with cerebral subcortical hemorrhage following the administration of phenylpropanolamine].
    Otomo S; Kubo J; Mihara B; Gomi S; Suga S
    Rinsho Shinkeigaku; 2001 Jul; 41(7):407-11. PubMed ID: 11808351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral arteritis following methylphenidate use.
    Schteinschnaider A; Plaghos LL; Garbugino S; Riveros D; Lazarowski A; Intruvini S; Massaro M
    J Child Neurol; 2000 Apr; 15(4):265-7. PubMed ID: 10805196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral infarction with a single oral dose of phenylpropanolamine.
    Edwards M; Russo L; Harwood-Nuss A
    Am J Emerg Med; 1987 Mar; 5(2):163-4. PubMed ID: 3828020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: Dexatrim (Phenylpropanolamine) as a cause of myocardial infarction.
    Pilsczek FH; Karcic AA; Freeman I
    Heart Lung; 2003; 32(2):100-4. PubMed ID: 12734532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric side effects attributed to phenylpropanolamine.
    Lake CR; Masson EB; Quirk RS
    Pharmacopsychiatry; 1988 Jul; 21(4):171-81. PubMed ID: 3060884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs.
    Cantu C; Arauz A; Murillo-Bonilla LM; López M; Barinagarrementeria F
    Stroke; 2003 Jul; 34(7):1667-72. PubMed ID: 12791938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral vasculitis in a drug abuser.
    Kessler JT; Jortner BS; Adapon BD
    J Clin Psychiatry; 1978 Jun; 39(6):559-64. PubMed ID: 659378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug effects attributed to phenylpropanolamine: a review of 142 case reports.
    Lake CR; Gallant S; Masson E; Miller P
    Am J Med; 1990 Aug; 89(2):195-208. PubMed ID: 2200264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracerebral haemorrhage and angiographic beading following ingestion of catecholaminergics.
    Stoessl AJ; Young GB; Feasby TE
    Stroke; 1985; 16(4):734-6. PubMed ID: 4024187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracerebral hemorrhage in a young woman with arteriovenous malformation after taking diet control pills containing phenylpropanolamine: a case report.
    Chung YT; Hung DZ; Hsu CP; Yang DY; Wu TC
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):432-5. PubMed ID: 9699397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurologic toxicity of methotrexate in a patient with cerebral arteritis. Report of a case].
    Guérin JM; Mofredj A; Leibinger F; Ekherian JM
    Rev Neurol (Paris); 1998 Oct; 154(10):700-2. PubMed ID: 9846341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced MR of cerebral arteritis: intravascular enhancement related to flow stasis within areas of focal arterial ectasia.
    Lazar EB; Russell EJ; Cohen BA; Brody B; Levy RM
    AJNR Am J Neuroradiol; 1992; 13(1):271-6. PubMed ID: 1595457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral infarcts in a pediatric patient secondary to phenylpropanolamine, a recalled medication.
    Delorio NM
    J Emerg Med; 2004 Apr; 26(3):305-7. PubMed ID: 15028328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posterior reversible encephalopathy syndrome complicating intracranial hemorrhage after phenylpropanolamine exposure.
    Kawanabe T; Tanaka R; Sakaguchi Y; Akiyama O; Shimura H; Yasumoto Y; Ito M; Hattori N; Tanaka S
    Neurol Med Chir (Tokyo); 2011; 51(8):582-5. PubMed ID: 21869581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylpropanolamine and the risk of hemorrhagic stroke.
    Kernan WN; Viscoli CM; Brass LM; Broderick JP; Brott T; Feldmann E; Morgenstern LB; Wilterdink JL; Horwitz RI
    N Engl J Med; 2000 Dec; 343(25):1826-32. PubMed ID: 11117973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracerebral hemorrhage and phenylpropanolamine use.
    Kase CS; Foster TE; Reed JE; Spatz EL; Girgis GN
    Neurology; 1987 Mar; 37(3):399-404. PubMed ID: 3822132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.